University of Leicester, Department of Cardiovascular Sciences, Leicester, UK.
Centre for Cardiovascular and Metabolic Neuroscience, Department of Neuroscience, Physiology and Pharmacology, University College London, London, UK.
Auton Neurosci. 2022 Jul;240:102985. doi: 10.1016/j.autneu.2022.102985. Epub 2022 May 1.
In this review we will examine the role of the autonomic nervous system in the control of cerebral blood flow (CBF) in dementia. Worldwide, 55 million people currently live with dementia, and this figure will increase as the global population ages. Understanding the changes in vascular physiology in dementia could pave the way for novel therapeutic approaches. Reductions in CBF have been demonstrated in multiple dementia sub-types, in addition to increased cerebrovascular resistance and reduced vasoreactivity. Cerebral autoregulation (CA) is a key mechanism for the maintenance of cerebral perfusion, but remains largely intact in cognitive disorders, despite reductions in global and regional CBF. However, the tight coupling between neuronal activity and CBF (neurovascular coupling - NVC) is lost in dementia, which may be a key driver of cognitive dysfunction. Despite numerous studies investigating disturbances in the control of CBF in dementia, less is known about the specific mechanisms responsible for the observed changes. Disturbances could be related to one of a number of pathways and mechanisms including disruption of the autonomic component. In this review we will explore clinical and animal studies, which specifically investigated the autonomic component of CBF control in dementia, drawing on the clinical implications and potential for novel biomarker and therapeutic targets.
在这篇综述中,我们将探讨自主神经系统在痴呆症患者大脑血液流量(CBF)控制中的作用。目前,全球有 5500 万人患有痴呆症,随着全球人口老龄化,这一数字还将增加。了解痴呆症中血管生理学的变化可能为新的治疗方法铺平道路。除了增加脑血管阻力和降低血管反应性外,多种痴呆症亚型都表现出 CBF 减少。脑自动调节(CA)是维持脑灌注的关键机制,但尽管全球和区域 CBF 减少,认知障碍患者的 CA 仍然基本保持完整。然而,在痴呆症中,神经元活动和 CBF 之间的紧密耦合(神经血管耦合-NVC)丧失,这可能是认知功能障碍的关键驱动因素。尽管有许多研究调查了痴呆症中 CBF 控制的紊乱,但对于导致观察到的变化的具体机制知之甚少。紊乱可能与许多途径和机制之一有关,包括自主成分的破坏。在这篇综述中,我们将探讨专门研究痴呆症中 CBF 控制自主成分的临床和动物研究,借鉴其临床意义和新型生物标志物和治疗靶点的潜力。